Effectiveness of Injectable Extended-Release Naltrexone vs Daily Buprenorphine-Naloxone for Opioid Dependence-Reference-Cited by-同舟云学术

Effectiveness of Injectable Extended-Release Naltrexone vs Daily Buprenorphine-Naloxone for Opioid Dependence

Published:2017-12-01 Issue:12 Volume:74 Page:1197
ISSN:2168-622X
Container-title:JAMA Psychiatry
language:en
Short-container-title:JAMA Psychiatry

Author:

Tanum Lars¹,Solli Kristin Klemmetsby²,Latif Zill-e-Huma³,Benth Jurate Šaltyte⁴,Opheim Arild⁵,Sharma-Haase Kamni⁶,Krajci Peter⁷,Kunøe Nikolaj²

Affiliation:

1. The Norwegian Centre for Addiction Research, The University of Oslo, Oslo, Norway2Department.of Research and Development in Mental Health Service, Akershus University Hospital, Lorenskog, Norway

2. The Norwegian Centre for Addiction Research, The University of Oslo, Oslo, Norway

3. Department.of Research and Development in Mental Health Service, Akershus University Hospital, Lorenskog, Norway

4. Institute of Clinical Medicine, Campus Ahus, University of Oslo, Oslo, Norway4Health Services Research Unit, Akershus University Hospital, Lorenskog, Norway

5. Department of Addiction Medicine, Haukeland University Hospital, Haukeland, Norway6Faculty of Medicine & Odontology, The University of Bergen, Bergen, Norway

6. The Norwegian Centre for Addiction Research, The University of Oslo, Oslo, Norway7Department of Addiction Medicine, Vestfold Hospital Trust, Tonsberg, Norway

7. Department of Addiction Medicine, Oslo University Hospital, Oslo, Norway

Publisher

American Medical Association (AMA)

Subject

Psychiatry and Mental health

Cited by 207 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Engaging healthcare teams to increase access to medications for opioid use disorder;Health Services Research;2024-09-08

2. Medial prefrontal neuroplasticity during extended-release naltrexone treatment of opioid use disorder – a longitudinal structural magnetic resonance imaging study;Translational Psychiatry;2024-09-05

3. Emergency department management of opioid use disorder in pediatric patients;Journal of the American College of Emergency Physicians Open;2024-08-25

4. Comparative effectiveness of extended‐release naltrexone and sublingual buprenorphine for treatment of opioid use disorder among Medicaid patients;Addiction;2024-08-05

5. A pilot randomized controlled trial of medication adherence therapy: Psychosocial leverage using a significant other (MAT-PLUS) for individuals on extended-release naltrexone;Journal of Substance Use and Addiction Treatment;2024-08